PATENT CLAIM ANALYSIS

Application Number: 15960259
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "100000"]

Abstract:
The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein R 1 -R 3  are as defined herein, or pharmaceutically acceptable salts or esters thereof; and a pharmaceutically acceptable carrier.

Claim (Index 56):
The method of  claim 55 , wherein the cancer is a B-RAF mutated cancer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13794635', '12180408', '12595357', '14026591', '13976876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8008970784923426
- 35 USC 102 Novelty (BERT): 0.5488563090405107
- Combined Prediction Score: 0.7756930015471595
- Mean Citation Score: 334.7711240000001
- Max Citation Score: 423.09964
- Similarity Product: 259.6981761919022

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test